Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Other Accumulated Expenses (2017 - 2025)

Historic Other Accumulated Expenses for Cirtran (CIRX) over the last 13 years, with Q3 2025 value amounting to $1.8 million.

  • Cirtran's Other Accumulated Expenses fell 1475.05% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 1475.05%. This contributed to the annual value of $1.9 million for FY2024, which is 544.6% up from last year.
  • Cirtran's Other Accumulated Expenses amounted to $1.8 million in Q3 2025, which was down 1475.05% from $1.6 million recorded in Q2 2025.
  • Cirtran's 5-year Other Accumulated Expenses high stood at $2.2 million for Q2 2024, and its period low was $793128.0 during Q4 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $1.6 million (2025), whereas its average is $1.5 million.
  • In the last 5 years, Cirtran's Other Accumulated Expenses surged by 9296.27% in 2022 and then crashed by 2824.82% in 2025.
  • Over the past 5 years, Cirtran's Other Accumulated Expenses (Quarter) stood at $793128.0 in 2021, then skyrocketed by 92.96% to $1.5 million in 2022, then rose by 14.95% to $1.8 million in 2023, then rose by 5.45% to $1.9 million in 2024, then decreased by 4.54% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.6 million for Q2 2025, and $1.7 million during Q1 2025.